Bradford K. Amman - 25 Feb 2022 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chief Financial Officer
Signature
/s/ Bradford K. Amman
Issuer symbol
VVOS
Transactions as of
25 Feb 2022
Net transactions value
+$163,500
Form type
4
Filing time
28 Feb 2022, 17:50:54 UTC
Previous filing
02 Sep 2021
Next filing
28 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VVOS Stock Option (Right to Buy) Award $163,500 +50,000 $3.27* 50,000 25 Feb 2022 Common Stock 50,000 $3.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 stock options granted on February 25, 2022. One-fifth vested immediately and one-fifth vests annually on each anniversary date through February 25, 2026.